Birdwatch Note Rating
2025-06-07 04:35:13 UTC - SOMEWHAT_HELPFUL
Rated by Participant: BD73C3896C802C0972F48E6E9614453B1DF769A6AF62361C69279B2723DAA767
Participant Details
Original Note:
Remdesivir did not increase risk of death from Ebola, but it was inferior to other studied treatments in the treatment of Ebola. About 53% of patients receiving remdesivir died from Ebola in the trial compared to 35% with the superior therapeutics. https://www.nih.gov/news-events/news-releases/investigational-drugs-reduce-risk-death-ebola-virus-disease https://pmc.ncbi.nlm.nih.gov/articles/PMC7250494
All Note Details